Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PeerJ ; 12: e17083, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38590705

RESUMO

Studies focusing on the safety and common side effects of vaccines play a crucial role in enhancing public acceptance of vaccination. Research is scarce regarding the usage of COVID-19 vaccines and the side effects experienced by health professions students in India and other countries. This study aimed to document self-reported side effects associated with COVID-19 vaccination among medical and dental students of six medical and dental colleges and teaching hospitals in four states (Tamil Nadu, Madhya Pradesh, Gujarat, and West Bengal) of India. A cross-sectional survey using purposive sampling of medical and dental students was conducted from 26 April to 26 May 2021. Data was collected using a Google Forms questionnaire capturing information regarding receiving COVID-19 vaccines, side effects and symptoms, onset and duration of symptoms, use of treatment to alleviate symptoms, awareness of haematologic risks associated with vaccination, and side effects from previous (non-COVID-19) vaccinations. The majority (94.5%) of participants received both doses of the Covishield/AstraZeneca COVID-19 vaccine. Among participants (n = 492), 45.3% (n = 223) reported one or more side effects. The most frequently reported side effects were soreness of the injected arm (80.3%), tiredness (78.5%), fever (71.3%), headache (64.1%), and hypersomnia (58.7%). The two most common severe symptoms were fever (14.8%) and headache (13%). Most side effects appeared on the day of vaccination: soreness of the injection site (57%), fever (43.1%), and tiredness (42.6%). Most reported symptoms persisted for one to three days-soreness of the injection site (53%), fever (47.1%), and headache (42.6%). Logistic regression showed that women were almost 85% less likely to report side effects. The study's findings corroborate the safety of the Covishield/AstraZeneca vaccine's first dose, evidenced by the relatively minor and transient nature of the side effects. However, the study underscores the necessity for ongoing research to assess the long-term impacts of COVID-19 vaccines, especially in the context of booster doses, thereby contributing to the global understanding of vaccine safety and efficacy.


Assuntos
COVID-19 , Estudantes de Ciências da Saúde , Feminino , Humanos , ChAdOx1 nCoV-19 , COVID-19/epidemiologia , Vacinas contra COVID-19/efeitos adversos , Estudos Transversais , Fadiga , Febre , Cefaleia , Ocupações em Saúde , Índia/epidemiologia , Dor , Autorrelato , Masculino
2.
J Clin Diagn Res ; 6(10): 1732-5, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23373039

RESUMO

BACKGROUND: The Gestational Age (GA) is frequently over or under estimated, as the conventional gestational estimation is based on the Last Menstrual Period (LMP) and on ultrasonography (USG). Many people are unaware of their LMP and irregular menstruations and USG is bound to have a bias, thereby posing difficulties in the GA estimation. AIM: This study was aimed at estimating the (Placental Thickness) PT and at investigating the relationship between PT and the foetal growth parameters in normal singleton pregnancies. MATERIALS AND METHODS: Two hundred eleven pregnant women were recruited in a cross sectional prospective study. The pregnancies were between 11 to 40 weeks and they were not complicated by either maternal or foetal diseases. The Biparietal Diameter (BPD), the Abdominal Circumference (AC), the Head Circumference (HC), the Femur Length (FL) and the PT were measured by USG by using a 3.5 MHz transducer. RESULTS: The maximum mean PT in the 1st, 2nd, 3rd and the combined trimesters were 16.5 mm, 23.78 mm, 35.81 mm and 28.49 mm respectively. The correlation between PT and the other foetal parameters was investigated by Pearson's correlation analysis. The values were expressed as mean + standard deviation. The statistical tests were two-tailed, with a p value of < 0.01, which indicated the statistical significance. There was a strong positive correlation between PT and GA, with the correlation coefficient values for the 1st, 2nd and 3rd trimesters being r = 0.609, r = 0.812 and r = 0.814 respectively. There was a significant positive correlation between PT and BPD, AC, FL, ABC, HC and FW also. The mathematical relationships between PT and GA, BPD, AC, FL, ABC, HC, FW were derived by regression analysis. The regression equation which was derived was (x - 22.92) = (0.3604) (w-27.86446) + (1.0256)(y-1.1678) + (0.0015)(z-216.2841) + (0.1047) (t-43.1555) + (0.027) (u.192.79000) + (0.0042) (v-60.3725), where x = GA in weeks, w = PT in mm, y = FW in kg, z = HC in mm, t = FL in mm, u = AC in mm and v = BPD in mm. CONCLUSION: We conclude that PT can be used as a predictor of the GA. The subnormal PT for the corresponding GA should be evaluated for any disease condition. So, the measurement of PT should therefore be carried out routinely during the obstetric USGs.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...